The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
Open accessAbstract
Importance: Elevated systolic blood (SBP) pressure is a leading global health risk. Quantifying the levels of SBP is important to guide prevention policies and interventions. Objective: To estimate the association between SBP of at least 110 to 115 mm Hg and SBP of 140 mm Hg or higher and the burden of different causes of death and disability by age and sex for 195 countries and territories, 1990-2015. Design: A comparative risk assessment of health loss related to SBP. Estimated distribution of SBP was based on 844 studies from 154 countries (published 1980-2015) of 8.69 million participants. Spatiotemporal Gaussian process regression was used to generate estimates of mean SBP and adjusted variance for each age, sex, country, and year. Diseases with sufficient evidence for a causal relationship with high SBP (eg, ischemic heart disease, ischemic stroke, and hemorrhagic stroke) were included in the primary analysis. Main Outcomes and Measures: Mean SBP level, cause-specific deaths, and health burden related to SBP (≥110-115 mm Hg and also ≥140 mm Hg) by age, sex, country, and year. Results: Between 1990-2015, the rate of SBP of at least 110 to 115 mm Hg increased from 73 119 (95% uncertainty interval [UI], 67 949-78 241) to 81 373 (95% UI, 76 814-85 770) per 100 000, and SBP of 140 mm Hg or higher increased from 17 307 (95% UI, 17 117-17 492) to 20 526 (95% UI, 20 283-20 746) per 100 000. The estimated annual death rate per 100 000 associated with SBP of at least 110 to 115 mm Hg increased from 135.6 (95% UI, 122.4-148.1) to 145.2 (95% UI 130.3-159.9) and the rate for SBP of 140 mm Hg or higher increased from 97.9 (95% UI, 87.5-108.1) to 106.3 (95% UI, 94.6-118.1). For loss of DALYs associated with systolic blood pressure of 140 mm Hg or higher, the loss increased from 95.9 million (95% uncertainty interval [UI], 87.0-104.9 million) to 143.0 million (95% UI, 130.2-157.0 million) [corrected], and for SBP of 140 mm Hg or higher, the loss increased from 5.2 million (95% UI, 4.6-5.7 million) to 7.8 million (95% UI, 7.0-8.7 million). The largest numbers of SBP-related deaths were caused by ischemic heart disease (4.9 million [95% UI, 4.0-5.7 million]; 54.5%), hemorrhagic stroke (2.0 million [95% UI, 1.6-2.3 million]; 58.3%), and ischemic stroke (1.5 million [95% UI, 1.2-1.8 million]; 50.0%). In 2015, China, India, Russia, Indonesia, and the United States accounted for more than half of the global DALYs related to SBP of at least 110 to 115 mm Hg. Conclusions and Relevance: In international surveys, although there is uncertainty in some estimates, the rate of elevated SBP (≥110-115 and ≥140 mm Hg) increased substantially between 1990 and 2015, and DALYs and deaths associated with elevated SBP also increased. Projections based on this sample suggest that in 2015, an estimated 3.5 billion adults had SBP of at least 110 to 115 mm Hg and 874 million adults had SBP of 140 mm Hg or higher.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Over 50% of heart disease, stroke, and heart failure are caused by increased blood pressure.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [7]
In the citing paper
“Hypertension causes over 40% of deaths in people with dia -betes 11 and is also a leading risk for fetal and maternal death in pregnancy, dementia, and renal failure (particularly in people of African ancestry) and can cause blindness.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Self-citationLim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Self-citationGlobal burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,698
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
Self-citationA Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492
Self-citationBlood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Research works printed but not linked: 4
- Wright JT Jr, Bakris G, Greene T, et al; African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. JAMA. 2002;288(19):2421-2431.
- Murray CJL, Lopez AD. Global mortality, disability, and the contribution of risk factors. Lancet. 1997;349(9063):1436-1442.
- Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010. Lancet. 2012;380 (9859):2224-2260.
- Piper MA, Evans CV, Burda BU, et al. Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the US Preventive Services Task Force. Rockville (MD). US: Agency for Healthcare Research and Quality; 2014. http://www .ncbi.nlm.nih.gov/books/NBK269495/. Accessed December 17, 2015.
Cited by
Sorted by citations
Items 601–700 of 1,001
Katamba, G., Agaba, D. C., Migisha, R., Namaganda, A., Namayanja, R., & Turyakira, E. (2020) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-020-00841-4 · Cited by 24
Hisamatsu, T., Miura, K., Ohkubo, T., Kadota, A., Kondo, K., Kita, Y., Hayakawa, T., Kanda, H., Okamura, T., Okayama, A., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002533 · Cited by 21
“H ypertension is the leading cause of morbidity and mortality of cardiovascular disease (CVD) worldwide [1].”
BackgroundSelf-citationKuneinen, S. M., Kautiainen, H., Ekblad, M. O., & Korhonen, P. E. (2024) · Journal of Human Hypertension · doi:10.1038/s41371-024-00900-x · Cited by 20
UMOD Genotype-Blinded Trial of Ambulatory Blood Pressure Response to Torasemide
McCallum, L., Lip, S. Z. L., McConnachie, A., Brooksbank, K. J. M., MacIntyre, I. M., Doney, A. S. F., Llano, A., Aman, A., Caparrotta, T. M., Ingram, G., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23122 · Cited by 20
Taheri, A., Khezri, R., Dehghan, A., Rezaeian, M., Aune, D., & Rezaei, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-69062-7 · Cited by 20
“High blood pressure is an important risk factor in the occurrence of CVD and kidney diseases 11,12 , which imposes a heavy economic burden on societies 13 .”
BackgroundMassussi, M., Bellicini, M. G., Adamo, M., Pilotto, A., Metra, M., Padovani, A., & Proietti, R. (2024) · ESC Heart Failure · doi:10.1002/ehf2.15144 · Cited by 23
Pescatello, L. S. (2018) · British Journal of Sports Medicine · doi:10.1136/bjsports-2018-100359 · Cited by 20
Antihypertensive Drugs and Risk of Cancer: Between Scylla and Charybdis
Sanidas, E. A., Velliou, M., Papadopoulos, D., Fotsali, A., Iliopoulos, D., Mantzourani, M., Toutouzas, K. P., & Barbetseas, J. D. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa098 · Cited by 20
Epidemiology of Hypertension and Diabetes Mellitus in Latin America
López-Jaramillo, P. A., López-López, J., Cohen, D. D., Alarcon-Ariza, N., & Mogollon-Zehr, M. (2020) · Current Hypertension Reviews · doi:10.2174/1573402116999200917152952 · Cited by 23
Oh, J. S., Lee, C. H., Park, J.-I., Park, H.-K., & Hwang, J. K. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e400 · Cited by 20
Effects of artichoke on blood pressure: A systematic review and meta-analysis
Moradi, M., Sohrabi, G., Golbidi, M., Yarmohammadi, S., Hemati, N., Campbell, M. S., Moradi, S., Kermani, M. A. H., & Farzaei, M. H. (2021) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2021.102668 · Cited by 20
Khanal, H., & Khanal, U. (2021) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2021.01.007 · Cited by 17
The Role of Inflammation as a Preponderant Risk Factor in Cardiovascular Diseases
García, R. D., Asensio, J. A., Perdicaro, D. J., & Peral, M. D. L. Á. (2022) · Current Vascular Pharmacology · doi:10.2174/1570161120666220201160038 · Cited by 21
Le, N. N., Tran, T., Lip, S. Z. L., McCallum, L., McClure, J., Dominiczak, A. F., Gill, D., & Padmanabhan, S. (2022) · Genes · doi:10.3390/genes13071226 · Cited by 23
Zhao, T., Zhang, L., Zhou, N., Sun, D., Xie, J., & Xu, S. (2022) · Food Science & Nutrition · doi:10.1002/fsn3.3069 · Cited by 21
Trieu, K., Coyle, D. H., Rosewarne, E., Shahid, M., Yamamoto, R., Nishida, C., Neal, B. C., He, F. J., Marklund, M., & Wu, J. H. Y. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20105 · Cited by 19
Self-citationFunctional Aging: Integrating Functionality to a Multidimensional Assessment of Healthy Aging
Frangos, E., Graf, C. E., & Samaras, N. (2023) · Current Gerontology and Geriatrics Research · doi:10.1155/2023/9409918 · Cited by 27
“, hemoglobin, glycated hemoglobin, cholesterol, albumin, CRP, cytokines, infammation factors, and chemokines), or physiological markers (blood pressure, lung function, or glomerular fltration), in an attempt to capture physiological changes along the aging courses and to assess health risks in individuals of the same…”
BackgroundA cross-tissue transcriptome association study identifies key genes in essential hypertension
Huang, S., Wang, J., Liu, N., Li, P., Wu, S., Qi, L., & Xia, L. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1114174 · Cited by 21
“Between 1990 and 2015, as the rate of elevated systolic pressure increased, so did the disabilities and deaths associated with it (Forouzanfar et al., 2017).”
BackgroundReiker, T., Rosiers, S. D., Boch, J., Partha, G., Venkitachalam, L., Santana, A., Srivasatava, A., Barboza, J., Byambasuren, E., Baxter, Y. C., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001480 · Cited by 20
“Hypertension or high blood pressure (BP) is the prime risk factor for CVD and accounts for over half of the stroke and CHD burden, causing 40% of stroke-related mortality [6,7].”
BackgroundThe interaction between hypertension and obstructive sleep apnea on subjective daytime sleepiness
Tam, W., Ng, S. S., To, K., Ko, F. W. S., & Hui, D. S. C. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13485 · Cited by 20
Amssayef, A., & Eddouks, M. (2019) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/1871525717666191007151413 · Cited by 20
A Meta-Analysis of Blood Pressure Disparities Among Sexual Minority Men
Castillo, H. L., Tfirn, I. C., Hegarty, E., Bahamon, I., & Lescano, C. M. (2021) · LGBT Health · doi:10.1089/lgbt.2019.0121 · Cited by 21
Zang, J., Liang, J., Zhuang, X., Zhang, S., Liao, X., & Wu, G. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-021-00494-8 · Cited by 20
Woo, H. G., Chang, Y., Lee, J. S., & Song, T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253257 · Cited by 20
Teng, H., Hu, J., Ge, W., Dai, Q., Ji, L., Xiao, C., Yin, J., & Zhu, X. (2021) · International Journal of Hypertension · doi:10.1155/2021/6646868 · Cited by 20
Byrd, J. B., & Brook, R. D. (2019) · Annals of Internal Medicine · doi:10.7326/aitc201905070 · Cited by 22
Liang, J., Li, Y., Chen, L., Xia, W., Wu, G., Tong, X., Su, C., He, J., Lin, X., & Tao, J. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2108-8 · Cited by 21
“Hypertension is one of major contributing factors to the development of atherosclerotic cardiovascular diseases (ASCVD) [1].”
BackgroundInfluentialKreutz, R. H., Algharably, E. A. E., Azizi, M., Dobrowolski, P., Guzik, T. J., Januszewicz, A., Persu, A., Prejbisz, A., Riemer, T., Wang, J., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab224 · Cited by 20
Lee, E. K. P., Wang, S., Ng, W., Ramdzan, S. N., Tse, E., Chan, L., Rashid, A., Chin, W., Yu, C., Sit, R. W. S., et al. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003783 · Cited by 19
Therapeutic inertia and contributing factors among ambulatory patients with hypertension
Niriayo, Y. L., Girmay, S., Tesfay, N., Gidey, K., & Asgedom, S. W. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04109-1 · Cited by 22
Wang, M., Wu, T., Yu, C., Gao, W., Lv, J., Wu, Y., Qin, X., Tang, X., Gao, P., Zhan, S., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035190 · Cited by 19
Ghorani, H. A., Kulenthiran, S., Lauder, L., Böhm, M., & Mahfoud, F. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-020-00477-1 · Cited by 21
“Arterial hypertension is the most frequent modifiable risk factor associated with cardiovascular morbidity and mortality [1].”
BackgroundWehkamp, K., Kiefer, F. B., Geiger, F., Scheibler, F., Rueffer, J. U., Donner‐Banzhoff, N., & Betsch, C. (2021) · Patient Preference and Adherence · doi:10.2147/ppa.s311470 · Cited by 19
Primary Hypertension Beginning in Childhood and Risk for Future Cardiovascular Disease
Falkner, B. E., & Lurbe, E. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.08.008 · Cited by 20
Trends and age-period-cohort effects on hypertension mortality rates from 1998 to 2018 in Mexico
Castro-Porras, L. V., Rojas, R., Aguilar-Salinas, C. A., Bello‐Chavolla, O. Y., Becerril-Gutiérrez, C., & Escamilla-Núñez, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-96175-0 · Cited by 19
Ethnic Differences in the Prevalence of Hypertension in Colombia: Association With Education Level
López-López, J., Cohen, D. D., Alarcon-Ariza, N., Mogollon-Zehr, M., Ney-Salazar, D., Chacón-Manosalva, M. A., Martínez-Bello, D., Otero, J. A., Castillo-Lopez, G., Pérez-Mayorga, M., et al. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac051 · Cited by 19
Estimating cardiovascular health gains from eradicating indoor cold in Australia
Singh, A., Mizdrak, A., Daniel, L., Blakely, T. A., Baker, E., Alfonzo, L. F., & Bentley, R. (2022) · Environmental Health · doi:10.1186/s12940-022-00865-9 · Cited by 22
“Relative risks for the causal relationship between systolic blood pressure and ischemic heart disease, ischemic stroke and haemorrhagic stroke were obtained from the Global Burden of Disease (GBD) study [20] (see supplementary Table 5).”
MethodPlasma Lipidomic Subclasses and Risk of Hypertension in Middle-Aged and Elderly Chinese
Niu, Z., Wu, Q., Luo, Y., Wang, D., Zheng, H., Wu, Y., Yang, X., Zeng, R., Sun, L. T., & Lin, X. (2022) · Phenomics · doi:10.1007/s43657-022-00057-y · Cited by 19
Sikorski, V., Vento, A. E., & Kankuri, E. M. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.07.018 · Cited by 20
“It is considered the leading cardiovascular disease to cause premature deaths.(242) While hypertension represents a prototypic multifactorial disease with multiple risk factors and varying etiologies, essential hypertension, where no specific etiology is identified, comprises 90% of cases and has been defined as a vas…”
BackgroundKumrić, M., Vrdoljak, J., Dujić, G., Šupe‐Domić, D., Kurir, T. T., Dujić, Ž., & Božić, J. (2022) · Biomolecules · doi:10.3390/biom12091204 · Cited by 19
“Affecting more than a quarter of the world’s population and representing the biggest single risk factor contributing to the global all-cause mortality, hypertension represents a major healthcare issue [1,2].”
BackgroundThe gut microbiome and obstructive sleep apnea syndrome in children
Liu, W., Du, Q., Zhang, H., & Han, D. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.09.022 · Cited by 21
Fenton, T. R., Elmrayed, S. A., Scime, N. V., Tough, S., Pinto, J., Sabet, F., Wollny, K., Lee, Y., Harrison, T. G., Alladin, B., et al. (2023) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12955 · Cited by 19
Ivanova, T. I., Churnosova, M., Abramova, M. Y., Plotnikov, D., Ponomarenko, I., Reshetnikov, E., Aristova, I., Николаевна, С. И., & Churnosov, M. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097799 · Cited by 20
“692 million) are observed in the value for DALYs correlated with SBP ≥ 110–115 mm Hg [2].”
BackgroundWang, L., Zhang, H., Yao, H., Gong, C., Zhong, J., Liu, D., & Liang, Z. (2023) · Clinical Cardiology · doi:10.1002/clc.24079 · Cited by 22
“During the recent three decades, the prevalence of elevated systolic blood pressure (SBP ≥ 140mmHg) substantially increased, and disability‐adjusted life‐years and deaths associated with elevated blood pressure also increased.(1) In the United States, the prevalence”
BackgroundBakris, G. L., Chen, C., Campbell, A. K., Ashton, V., Haskell, L. P., & Singhal, M. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14701 · Cited by 18
Kowalski, S., Goniewicz, K., Moskal, A., Al-Wathinani, A. M., & Goniewicz, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175495 · Cited by 19
“According to the World Health Organization (WHO), HA is a primary risk factor for the onset of cardiovascular diseases, currently leading the charts as the top cause of mortality worldwide [1,2].”
BackgroundLei, L., Hui, S., Chen, Y., Yan, H., Yang, J., & Tong, S. (2024) · Nutrition Journal · doi:10.1186/s12937-024-00932-6 · Cited by 19
Mkuu, R. S., Gilreath, T. D., Wekullo, C. S., Reyes, G. A., & Harvey, I. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221257 · Cited by 19
Bernabé‐Ortiz, A., Pauschardt, J., Diez‐Canseco, F., & Miranda, J. J. (2020) · Journal of Medical Internet Research · doi:10.2196/14595 · Cited by 20
Dietary Mineral Intake from Nuts and Its Relationship to Hypertension Among Korean Adults
Bae, Y., Kim, M., & Choi, M. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-02952-3 · Cited by 19
“Hypertension alone is associated with 14% of mortality worldwide [2].”
BackgroundShin, J., Hong, S., Choi, S. Y., Rath, M., Saredy, J., Jovin, D. G., Sayoc, J., Park, H.-S., Eguchi, S., Rizzo, V., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102252 · Cited by 19
Myanganbayar, M., Baatarsuren, U., Chen, G., Campbell, N. R. C., Bosurgi, R., So, G., Unurjargal, T., Dashtseren, M., Tserengombo, N., Batsukh, B., et al. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13592 · Cited by 19
Satoh, M., Maeda, T., Hoshide, S., & Ohkubo, T. (2019) · Hypertension Research · doi:10.1038/s41440-019-0280-0 · Cited by 19
Self-citationYang, D.-Y. D., Nie, Z., Liao, L., Zhang, S., Zhou, H., Sun, X., Zhong, X., Du, Z., Zhuang, X., & Liao, X. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319856733 · Cited by 18
Dominguez, L. J., Gea, A., Ruiz-Estigarribia, L., Sayón-Orea, C., Fresán, U., Barbagallo, M., Ruiz‐Canela, M., & Martínez‐González, M. Á. (2020) · Nutrients · doi:10.3390/nu13010125 · Cited by 18
Xu, X., Bao, H., Tian, Z., Zhu, H., Zhu, L., Niu, L., Yan, T., Dong, H., Fang, X. L., & Zhang, X. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02333-7 · Cited by 18
May Measurement Month 2019: results of blood pressure screening from 47 countries
Poulter, N. R., Borghi, C., Damasceno, A. A. M., Jafar, T. H., Khan, N. A., Kokubo, Y., Nilsson, P. M., Prabhakaran, D., Schlaich, M. P., Schutte, A. E., et al. (2021) · European Heart Journal Supplements · doi:10.1093/eurheartj/suab014 · Cited by 18
Self-citationFragmented Sleep and the Prevalence of Hypertension in Middle-Aged and Older Individuals
Zhao, J., Wang, W., Wei, S., Yang, L., Wu, Y., & Yan, B. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s337932 · Cited by 18
Lee, N. S., Anastos-Wallen, R., Chaiyachati, K. H., Reitz, C., Asch, D. A., & Mehta, S. J. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.43590 · Cited by 19
Malta, D. C., Bernal, R. T. I., Prates, E. J. S., de Vasconcelos, N. M., Gomes, C. S., Stopa, S. R., Sardinha, L. M. V., & Pereira, C. A. (2022) · Epidemiologia e Serviços de Saúde · doi:10.1590/ss2237-9622202200012.especial · Cited by 20
Markers of Kidney Tubular Secretion and Risk of Adverse Events in SPRINT Participants with CKD
Bullen, A. L., Ascher, S. B., Scherzer, R., Garimella, P. S., Katz, R., Hallan, S. I., Cheung, A. K., Raphael, K. L., Estrella, M. M., Jotwani, V., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022010117 · Cited by 18
Santos, H. O., Martins, C. E. C., Forbes, S. C., & Delpino, F. M. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.03.016 · Cited by 20
Less sodium, more potassium, or both: population-wide strategies to prevent hypertension
Nissaisorakarn, V., Ormseth, G., Earle, W., Alvarez, M. C. M., Hiremath, S. S., & Juraschek, S. P. (2023) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00007.2023 · Cited by 18
Elias, S., & Kabeta, T. (2023) · Advances in Medicine · doi:10.1155/2023/2746284 · Cited by 18
“4 million deaths per year globally [1, 2].”
Wang, M., Zhang, L., Ma, J., Sun, H., Gao, Z., Hu, M., Liu, H., & Guo, L. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1116263 · Cited by 20
Li, J., Hong, Y., Zhong, Y., Yang, S., Pei, L., Huang, Z., Long, H., Chen, X., Zhou, C., Zheng, G., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167113 · Cited by 17
He, L., Zhang, M., Zhao, Y., Li, W., & Zhang, Y. (2024) · BMC Public Health · doi:10.1186/s12889-024-19189-z · Cited by 19
“As a primary contributor to cardiovascular diseases (CVDs), it significantly adds to global morbidity and mortality [3].”
BackgroundSuo, Q., Wang, J., Wu, N., Geng, L., Zhang, Q., & Yang, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135873 · Cited by 18
Campbell, N. R. C., Dashdorj, N., Baatarsuren, U., Myanganbayar, M., Dashtseren, M., Unurjargal, T., Zhang, X., Veiga, E. V., Beheiry, H., Mohan, S., et al. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.13079 · Cited by 18
Wolf, M. A., Hubbard, B. S., Sakaoka, A., Rousselle, S. D., Téllez, A., Jiang, X., Kario, K., Hohl, M., Böhm, M., & Mahfoud, F. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001840 · Cited by 18
Andersson, B., She, L., Tan, R., Jeemon, P., Mokrzycki, K., Siepe, M., Romanov, A. B., Favaloro, L. E., Djokovic, L. T., Raju, P. K., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy438 · Cited by 18
Savitha, M. N., Siddesha, J. M., Suvilesh, K. N., Manjunath, Y., Kameshwar, V. H., D’Souza, C. J. M., Umashankara, M., & Vishwanath, B. S. (2018) · Peptides · doi:10.1016/j.peptides.2018.11.002 · Cited by 18
“Currently, the global burden of hypertension is around 30% percent and expected to become a leading cause of mortality in the upcoming years [1,2].”
The Spice For Hypertension: Protective Role of Curcuma Longa
Leong, X.-F. (2018) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1555 · Cited by 18
Targeting blood pressure for stroke prevention: current evidence and unanswered questions
Béjot, Y. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09443-5 · Cited by 18
Looking back and thinking forwards — 15 years of cardiology and cardiovascular research
Kalman, J. M., Lavandero, S., Mahfoud, F., Nahrendorf, M., Yacoub, M. H., & Zhao, D. H. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0261-7 · Cited by 17
Pei, L., Wu, J., Wang, Z., Wang, X., Chen, Z., Li, J., Zhang, L., Fan, R., Zhang, Z., Dong, Y., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002352 · Cited by 18
Systems Genetics for Mechanistic Discovery in Heart Diseases
Rau, C. D., Lusis, A. J., & Wang, Y. (2020) · Circulation Research · doi:10.1161/circresaha.119.315863 · Cited by 19
Reference values for resting and post exercise hemodynamic parameters in a 6–18 year old population
Havasi, K., Maróti, Z., Jakab, A., Rasko, I., Kalmár, T., & Bereczki, C. (2020) · Scientific Data · doi:10.1038/s41597-020-0368-z · Cited by 10
Managing hypertension in 2018: which guideline to follow?
Angeli, F., Reboldi, G., Trapasso, M., Aita, A., & Verdecchia, P. (2019) · Heart Asia · doi:10.1136/heartasia-2018-011127 · Cited by 17
Golestaneh, A. K., Clarke, J., Appelbaum, N., Gonzálvez, C. R., Jose, A. P., Philip, R., Poulter, N. R., & Beaney, T. E. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06782-w · Cited by 22
Yen, H., & Huang, W. (2021) · Journal of Nursing Scholarship · doi:10.1111/jnu.12740 · Cited by 20
Shin, J., Konlan, K., & Mensah, E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260411 · Cited by 21
“It is noted that reducing the diastolic blood pressure in the general population by 2mmHg would be expected to reduce the incidence of hypertension (17%), stroke (14%), and coronary artery disease by 6% [6,15].”
BackgroundOsman, E. E., Shitie, D., Yirsaw, M. T., & Wale, M. Z. (2022) · SAGE Open Medicine · doi:10.1177/20503121221094223 · Cited by 17
Ross, S., Chadha, K., Mishra, S., Lewington, S., Shepperd, S., Gathani, T., collaborators, O. B. O. T. N. S., Albert, S., Bhatnagar, A., Chadha, K., et al. (2022) · BMC Public Health · doi:10.1186/s12889-022-13818-1 · Cited by 17
“1% for women, and this is likely to reflect the younger age distribution of the NHFS-5 survey, as increasing incidence of hypertension is associated with increasing age [30].”
BackgroundKisigo, G., Mcharo, O., Robert, J. L., Peck, R. N., Sundararajan, R. L., & Okello, E. S. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000919 · Cited by 20
Factors Associated With Blood Pressure Control Among Patients in Community Health Centers
Huguet, N., Green, B. B., Voss, R., Larson, A. E., Angier, H. E., Marino, M., Liu, S., Latkovic‐Taber, M., & DeVoe, J. E. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2022.11.002 · Cited by 17
Wu, L., Liu, M., Huang, C., Yin, J., Zhou, H. R., & Hu, H. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-03879-1 · Cited by 17
Hlyan, N. P., Arif, T., Jaufar, S. S., Rehman, A., Ayalew, B. D., Batu, B. J., Hundesa, M. I., Hlaing, M. S., Islam, H., Islam, R., et al. (2024) · Cureus · doi:10.7759/cureus.57241 · Cited by 19
“It affects ~20-25% of the global adult population conferring a 2-fold increase in cardiovascular outcomes and a 1.5-fold increase in all-cause mortality [3].”
InfluentialEpidemiology of hypertension in Fulani indigenous populations—age, gender and drivers
Kufe, C. N., Ngufor, G., Mbeh, G. N., & Mbanya, J. C. (2017) · Journal of Health Population and Nutrition · doi:10.1186/s41043-017-0112-2 · Cited by 17
Msemo, O. A., Schmiegelow, C., Nielsen, B. B., Kousholt, H., Grunnet, L. G., Christensen, D. L., Lusingu, J., Møller, S. L., Kavishe, R. A., Minja, D. T. R., et al. (2018) · Tropical Medicine & International Health · doi:10.1111/tmi.13149 · Cited by 17
“5 billion people and the leading cause of cardiovascular mortality worldwide [5].”
BackgroundKim‐Mitsuyama, S., Soejima, H., Yasuda, O., Node, K., Jinnouchi, H., Yamamoto, E., Sekigami, T., Ogawa, H., & Matsui, K. (2019) · Hypertension Research · doi:10.1038/s41440-019-0210-1 · Cited by 17
Association of handgrip strength with the prevalence of hypertension in a Chinese Han population
Mallah, M. A., Liu, M., Liu, Y., Xu, H., Wu, X., Chen, X., Wang, H., Liu, C., Tian, Y., Li, M., et al. (2019) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2019.05.004 · Cited by 17
“As one of the main causes of cardiovascular disease (CVD), hypertension accounts for ten million deaths every year,(3) contributing to the heavy burden of chronic cardiovascular diseases globally.(4,5) Hypertension is more prevalent in the older population and is closely related to behavioral risk factors, such as an…”
BackgroundSaif‐Ur‐Rahman, K., Islam, S. S., Hasan, M. N., Hossain, S., Mamun, R., Shafique, S., Mamun, A., Khalequzzaman, M., Haseen, F., Rahman, A., et al. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0223-x · Cited by 17
Prevalence of Hypertension in Renal Diseases in Iran: Systematic Review and Meta-Analysis
Motedayen, M., Sarokhani, D., Ghiasi, B., Khatony, A., & Dehkordi, A. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_522_18 · Cited by 17
Rivasi, G., Brignole, M., Rafanelli, M., Bilo, G., Pengo, M. F., Ungar, A., & Parati, G. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002555 · Cited by 18
Ma, C., Zheng, X., Yang, Y., & Bu, P. (2020) · Food & Function · doi:10.1039/d0fo02122a · Cited by 17
MacDonald, C., Madika, A., Lajous, M., Laouali, N., Artaud, F., Bonnet, F., Fagherazzi, G., & Boutron‐Ruault, M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015121 · Cited by 19
“risk factor for various forms of cardiovascular disease, 9 prevention is of the upmost importance.”
Increased AT1 receptor expression mediates vasoconstriction leading to hypertension in Snx1−/− mice
Liu, C., Li, X., Fu, J., Chen, K., Liao, Q., Wang, J., Chen, C., Luo, H., José, P. A., Yang, Y., et al. (2021) · Hypertension Research · doi:10.1038/s41440-021-00661-x · Cited by 18
“tension and its complications remain heavy burdens on global medical care [2, 3].”
BackgroundWang, C., Xing, C., Li, Z., Liu, Y., Li, Q., Wang, Y., Hu, J., Yuan, L., & Yang, G. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.06.005 · Cited by 17
Wang, Y., Jia, H., Gao, W., Zou, T., Yao, S., Du, M., Zhang, X., Chu, C., Liao, Y., Chen, C., et al. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002846 · Cited by 17
“H ypertension is a major public-health challenge worldwide because of its high prevalence and concomitant risks of cardiovascular disease and allcause mortality [1,2].”
Background
Metadata
- Authors
- Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., Alexander, L., Estep, K., Hassen Abate, K., Akinyemiju, T. F., Ali, R., Alvis-Guzman, N., Azzopardi, P., Banerjee, A., Bärnighausen, T., Basu, A., Bekele, T., Bennett, D. A., Biadgilign, S., Catalá-López, F., Feigin, V. L., Fernandes, J. C., Fischer, F., Gebru, A. A., Gona, P., Gupta, R., Hankey, G. J., Jonas, J. B., Judd, S. E., Khang, Y.-H., Khosravi, A., Kim, Y. J., Kimokoti, R. W., Kokubo, Y., Kolte, D., Lopez, A., Lotufo, P. A., Malekzadeh, R., Melaku, Y. A., Mensah, G. A., Misganaw, A., Mokdad, A. H., Moran, A. E., Nawaz, H., Neal, B., Ngalesoni, F. N., Ohkubo, T., Pourmalek, F., Rafay, A., Rai, R. K., Rojas-Rueda, D., Sampson, U. K., Santos, I. S., Sawhney, M., Schutte, A. E., Sepanlou, S. G., Shifa, G. T., Shiue, I., Tedla, B. A., Thrift, A. G., Tonelli, M., Truelsen, T., Tsilimparis, N., Ukwaja, K. N., Uthman, O. A., Vasankari, T., Venketasubramanian, N., Vlassov, V. V., Vos, T., Westerman, R., Yan, L. L., Yano, Y., Yonemoto, N., Zaki, M. E. S., & Murray, C. J. L.
- Affiliations
- University of Washington (US)
- Jimma University, Jimma, Ethiopia
- University of Alabama at Birmingham (US)
- University of Oxford (GB)
- Universidad de Cartagena, Cartagena de Indias, Colombia
- South Australian Health and Medical Research Institute (AU)
- Farr Institute (GB)
- Harvard University (US)
- University of Canterbury (NZ)
- Madda Walabu University (ET)
- Independent Public Health Consultants, Addis Ababa, Ethiopia
- Universitat de València (ES)
- Auckland University of Technology (NZ)
- Pharmacology and Experimental Therapeutics, IBILI - Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
- Bielefeld University (DE)
- Mekelle University (ET)
- University of Massachusetts Boston (US)
- Eternal Hospital (IN)
- The University of Western Australia (AU)
- Heidelberg University (DE)
- Seoul National University (KR)
- Ministry of Health and Medical Education (IR)
- Southern University College (MY)
- Simmons University (US)
- National Cerebral and Cardiovascular Center (JP)
- Brown University (US)
- University of Melbourne, Melbourne School of Population and Global Health, Melbourne, QLD, Australia
- Universidade de São Paulo (BR)
- Digestive Disease Research Institute (IR)
- The University of Adelaide (AU)
- National Institutes of Health (US)
- Columbia University (US)
- SIU Medicine (US)
- The University of Sydney (AU)
- Ministry of Health and Social Welfare (TZ)
- Teikyo University (JP)
- University of British Columbia (CA)
- Contech School of Public Health, Lahore, Punjab, Pakistan
- Society for Health and Demographic Surveillance, Suri, India
- ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain
- Marshall University (US)
- South African Medical Research Council (ZA)
- Southern Nations, Nationalities, and Peoples' Region (ET)
- Northumbria University (GB)
- James Cook University (AU)
- Monash Health (AU)
- University of Calgary (CA)
- University of Copenhagen (DK)
- Universität Hamburg (DE)
- Federal Teaching Hospital Abakaliki (NG)
- University of Warwick (GB)
- Urho Kaleva Kekkonen Institute (FI)
- Raffles Neuroscience Centre, Raffles Hospital, Singapore, Singapore
- National Research University Higher School of Economics, Moscow, Russia
- Federal Institute for Population Research (DE)
- Duke Kunshan University (CN)
- Northwestern University (US)
- National Center of Neurology and Psychiatry (JP)
- Mansoura University (EG)
- Corresponding author
- Murray, Christopher J. L.
- ORCID
- Forouzanfar, Mohammad H.
- Liu, Patrick
- Roth, Gregory A.
- Ng, Marie
- Marczak, Laurie
- Alexander, Lily
- Akinyemiju, Tomi F.
- Ali, Raghib
- Azzopardi, Peter
- Banerjee, Amitava
- Bärnighausen, Till
- Basu, Arindam
- Bennett, Derrick A.
- Biadgilign, Sibhatu
- Catalá-López, Ferrán
- Feigin, Valery L.
- Fischer, Florian
- Gona, Philimon
- Gupta, Rajeev
- Hankey, Graeme J.
- Jonas, Jost B.
- Judd, Suzanne E.
- Khang, Young-Ho
- Khosravi, Ardeshir
- Kim, Yun Jin
- Kimokoti, Ruth W.
- Kokubo, Yoshihiro
- Kolte, Dhaval
- Lotufo, Paulo A.
- Melaku, Yohannes Adama
- Mensah, George A.
- Misganaw, Awoke
- Mokdad, Ali H.
- Moran, Andrew E.
- Neal, Bruce
- Ohkubo, Takayoshi
- Pourmalek, Farshad
- Santos, Itamar S.
- Schutte, Aletta E.
- Sepanlou, Sadaf G.
- Shifa, Girma Temam
- Shiue, Ivy
- Tedla, Bemnet Amare
- Thrift, Amanda G.
- Tonelli, Marcello
- Tsilimparis, Nikolaos
- Ukwaja, Kingsley Nnanna
- Uthman, Olalekan A.
- Vasankari, Tommi
- Venketasubramanian, Narayanaswamy
- Vos, Theo
- Westerman, Ronny
- Yan, Lijing L.
- Yano, Yuichiro
- Yonemoto, Naohiro
- Zaki, Maysaa El Sayed
- Murray, Christopher J. L.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2017-01-10
- Volume
- 317
- Issue
- 2
- Pages
- 165
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2572331255
- Cited by
- 2,381
- References
- 56
- Citations by year
- 2026: 120 · 2025: 186 · 2024: 280 · 2023: 329 · 2022: 323 · 2021: 320 · 2020: 308 · 2019: 264 · 2018: 166 · 2017: 78
- FWCI
- 172.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion)
- ResearchOnline at James Cook University (James Cook University) (submittedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- UCL Discovery (University College London) (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Northumbria Research Link (Northumbria University) (submittedVersion)
- PUB – Publications at Bielefeld University (Bielefeld University) (submittedVersion)
- Publikationen an der Universität Bielefeld (Universität Bielefeld) (submittedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Bill and Melinda Gates Foundation
- Omron Healthcare
- National Institute for Health and Care Research (CL-2010-09-002)
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- hypertension, systolic blood pressure, global burden of disease, ischemic heart disease, ischemic stroke, hemorrhagic stroke, disability-adjusted life years, cause-specific mortality, cardiovascular disease, health loss, age and sex differences, spatiotemporal trends, cardiovascular risk factors, 1990-2015 trends
- MeSH terms
- Adult, Aged, Aged, 80 and over, Blood Pressure, Cause of Death, Female, Health Surveys, Humans, Hypertension, Male, Middle Aged, Monte Carlo Method, Systole, Global Health, Prevalence, Normal Distribution, Myocardial Ischemia, Age Distribution, Sex Distribution, Risk Assessment, Quality-Adjusted Life Years, Intracranial Hemorrhages, Stroke, Uncertainty, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
